The global skin cancer treatment market is expected to grow at a CAGR of XX% during the forecast period 2016-2021. The market was valued at USD XX million in 2015 and is forecasted to reach USD XX million by 2021.
As per the WHO, the incidence of both, non-melanoma and melanoma skin cancers, has been increasing over the past decade, with around 2 to 3 million non-melanoma skin cancers and 132,000 melanoma skin cancers occurring, globally, every year. Since 2011, eight new drugs have been FDA approved for the treatment of melanoma, including four immunotherapies and four targeted therapies. With over 50 drugs in the pipeline and major players like Roche, Merck, BMS, Novartis and Eisai investing heavily into R&D, the market for skin cancer treatment shows assured promise in the coming years.
Global Skin Cancer Treatment - Market Dynamics
The report details several factors driving and restraining the market, some of which are discussed below.
Increasing incidence of skin cancer
Extensive R&D pipelines
Increasing usage of combination therapies
Side-effects and complications associated with radiation therapy
Stringent regulatory guidelines
The global skin cancer treatment market has been segmented by type into melanoma and non-melanoma cases. The melanoma segment is further segmented into systemic and targeted immunotherapies. The systemic immunotherapies segment comprises checkpoint inhibitors (Yervoy, Keytruda, Opdivo) and oncolytic virus therapy (TVEC). The drugs associated with targeted immunotherapies are zelboraf, tafinlar, mekinist and cotellic. The non-melanoma skin cancer segment is further segmented into non-invasive treatment (laser therapy, radiotherapy, photodynamic therapy, cryotherapy, others) and chemotherapy treatment (systemic, targeted). The market has been geographically segmented into North America, Europe, Asia-Pacific, and Rest of the World.
Some of the key players in the market are:
F. Hoffmann-la Roche Ltd.
Valeant Pharmaceuticals Inc.
Novartis International AG
Varian Medical Systems Inc.
Merck & Co. Inc.
Eli Lilly and Co.
Bristol Myers Squibb Co.
Boehringer Ingelheim GmbH
Aqua Pharmaceuticals LLC
What the Report Offers
Market definition, along with identification of key drivers and restraints for the market.
Market analysis with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the industry on both global and regional scale.
A comprehensive list of key market players, along with the analysis of their current strategic interests and key financial information.
An ideal source material for industry consultants, manufacturers and other interested and allied parties to gain critical insight into the factors driving and restraining the market, in addition to opportunities, offered.
PDF E-mail From Publisher
Multi User License (2-5 Users) Fulfilled by Publisher